Skip to main content
. 2020 Feb 5;12(Suppl 1):65–71. doi: 10.1007/s13193-020-01046-1

Table 1.

Subject characteristics

Characteristics n (%)
Age
30–34 years 2 (1.6%)
35–39 years 6 (4.8%)
40–44 years 5 (4.0%)
45–49 years 6 (4.8%)
50–54 years 25 (20.2%)
55–59 years 28 (22.6%)
60–64 years 22 (17.7%)
65–69 years 10 (8.1%)
70–74 years 13 (10.5%)
75–79 years 6 (4.8%)
80–84 years 1 (0.8%)
Sex
Male 72 (58.1%)
Female 52 (41.9%)
Smoking status
Active Smoker 26 (21.0%)
Nonsmoker 64 (51.6%)
Ex-smoker 34 (27.4%)
Tissue origin
Open biopsy 5 (4.0%)
Core biopsy 18 (14.5%)
Bronchoalveolar lavage (BAL) 7 (5.6%)
Bronchial brushing 2 (1.6%)
FNAB lung 74 (59.7%)
FNAB cervical lymph node 4 (3.2%)
Pleural fluid cytology 14 (11.3%)
Diagnosis
Lung adenocarcinoma (right lung) 87 (70.2%)
Lung adenocarcinoma (left lung) 37 (29.8%)
Stage
IIA 2 (1.6%)
IIB 3 (2.4%)
IIIA 11 (8.9%)
IIIB 5 (4.0%)
IIIC 6 (4.8%)
IVA 83 (66.9%)
IVB 14 (11.3%)

FNAB fine-needle aspiration biopsy